Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Unit of Endocrinology, University Hospital of Pisa, Pisa, Italy.
Front Endocrinol (Lausanne). 2024 Oct 18;15:1414896. doi: 10.3389/fendo.2024.1414896. eCollection 2024.
Brown tumors are rare bone manifestations of primary hyperparathyroidism (PHPT) that may occur at different sites either as single or multiple lesions and they can easily be mistaken for malignant lesions. Neither bone site nor morphological or functional imaging are useful to drive the differential diagnosis and biopsy is often the only conclusive procedure.
We report the case of a 53 years-old man referred to our outpatient clinic for severe symptomatic PHPT complicated by nephrolithiasis and osteoporosis. Neck ultrasound and computed tomography (CT) scan showed a large irregular lesion posterior to the lower pole of the right thyroid lobe consistent with an enlarged parathyroid gland. Moreover, two bone lytic lesions were described at the left scapula and the contiguous 7 rib that showed an increased uptake at total bone scintigraphy. Given the clinical and biochemical picture, the features of the parathyroid lesion and the presence of bone lytic lesions, the suspicion of metastatic parathyroid carcinoma (PC) was raised. However, a CT-guided biopsy performed on the left scapula revealed a brown tumor. The patient underwent en-bloc resection of the right inferior parathyroid grand with the ipsilateral thyroid gland lobe. Histopathology confirmed the diagnosis of PC. Post-surgical biochemical evaluations showed that the patient was cured. A repeated total body CT scan revealed an osteoblastic appearance of the bone lesions ascribed to the partial regression of the brown tumors following surgery.
The implication of a diagnosis of brown tumor or bone metastasis is widely different; in fact, the first tends to regress with the surgical treatment of PHPT, whereas the latter has limited cure option and negatively affects the prognosis of patients. Therefore, although brown tumors are extremely rarer than in the past, they must always be taken into consideration in the presence of bone lesions, even in cases of high suspicion of malignancy, to avoid unnecessary and harmful surgical interventions.
棕色瘤是原发性甲状旁腺功能亢进症(PHPT)的罕见骨骼表现,可发生于不同部位,呈单发或多发病变,容易误诊为恶性病变。骨部位、形态或功能影像学均无助于鉴别诊断,活检通常是唯一的明确诊断方法。
我们报告了一例 53 岁男性患者,因严重症状性 PHPT 合并肾结石和骨质疏松症而被转诊至我院门诊。颈部超声和计算机断层扫描(CT)显示,右甲状腺下极后有一个大的不规则病变,符合甲状旁腺增大。此外,左侧肩胛骨和相邻的第 7 肋骨有两处溶骨性病变,全身骨扫描显示摄取增加。鉴于临床表现和生化特征、甲状旁腺病变的特征以及溶骨性病变的存在,怀疑为甲状旁腺癌(PC)转移。然而,在左侧肩胛骨上进行的 CT 引导活检显示为棕色瘤。患者接受了右侧下甲状旁腺和同侧甲状腺叶的整块切除术。组织病理学证实了 PC 的诊断。术后生化评估显示患者已治愈。重复全身 CT 扫描显示骨病变呈成骨表现,这归因于棕色肿瘤在手术后的部分消退。
棕色瘤或骨转移的诊断意义大不相同;实际上,前者随着 PHPT 的手术治疗而消退,而后者治愈的选择有限,并对患者的预后产生负面影响。因此,尽管棕色瘤比过去少见得多,但在存在骨病变的情况下,即使高度怀疑恶性病变,也必须始终考虑到棕色瘤,以避免不必要和有害的手术干预。